Skip to main content
What types of page to search?

Popular pages: Undergraduate Postgraduate PhD Accommodation Research International students

Alternatively use our A-Z index.

News

a syringe filled with light blue liquid

21 November 2025

Lupin launches risperidone long-acting injectable with 180-day CGT exclusivity in the US, the first product from its proprietary long-acting injectable platform
A syringe is being filled from a vial.

21 November 2025

LUPRON DEPOT® new strength receives Health Canada Approval for the treatment of advanced prostate cancer
a doctor is about to inject medicine into a patient\'s upper arm

21 November 2025

Arrivals of the twice-yearly PrEP option in Eswatini and Zambia mark an important milestone in the goal of ending the HIV epidemic in sub-Saharan Africa
a doctor is about to inject medicine into a patient\'s upper arm

21 November 2025

Phase 2 trial results show potential to shorten TB treatment time
A syringe is being filled from a vial in front of an HIV graphic

21 November 2025

Huge disparities in PrEP uptake across Europe – injectable PrEP largely inaccessible
A very close up and detailed image of a human eye

21 November 2025

EyePoint announce positive recommendation from Independent Data Safety Monitoring Committee for pivotal phase 3 trials for DURAVYU™ in wet AMD
an anatomical model of a heart

14 November 2025

Rona Therapeutics presents phase 1 data for RN0361, a long-acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions
A nurse preps a patient arm for an injection

14 November 2025

SanegeneBio and Innovent announce phase 1 clinical data for SGB-3908 presented at American Heart Association (AHA) 2025 annual meeting
insulin pen, diabetic measurement tools and pills on orange background

14 November 2025

ADOCIA announces filing of patent for new long-acting peptides platform in diabetes and obesity and provides an update on its BioChaperone® platform
MIT engineers have developed a flexible drug-delivery patch that can be placed on the heart after a heart attack to help promote healing and regeneration of cardiac tissue. The patch is designed to carry several different drugs that can be released at different times, on a pre-programmed schedule. (Image courtesy of the researchers)

7 November 2025

A new patch could help to heal the heart
a doctor is about to inject medicine into a patient\'s upper arm

30 October 2025

South Africa charts a new frontier by rolling out a twice-yearly injection which is almost 100% effective in preventing HIV
The flag of South Africa blowing in the wind against a blue sky.

30 October 2025

South Africa becomes first African country to register groundbreaking anti-HIV injection lenacapavir
A patient has just received an injection in their arm

24 October 2025

ADARx Pharmaceuticals dose first patient in phase 3 STOP-HAE clinical trial and orphan drug designation for ADX-324
A nurse preps a patient arm for an injection

17 October 2025

Lupin unveils strategic partnership program to expand reach of its long-acting injectable platform
A syringe is being filled from a vial.

17 October 2025

ViiV Healthcare showcases breadth of clinical and real-world evidence at EACS and IDWeek 2025
A syringe is being filled from a vial.

17 October 2025

FDA approves expanded indication for UZEDY® (risperidone) extended-release injectable suspension as a treatment for adults living with bipolar I disorder
A syringe is being filled from a vial.

17 October 2025

ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir
A person holds a red AIDS awareness ribbon out to the camera

17 October 2025

NHS to roll out first long-acting injection to prevent HIV
A nurse preps a patient arm for an injection

3 October 2025

Cabotegravir PrEP implant might prevent HIV for a year
A person is holiding an adult castor bean tick (Ixodes ricinus) caught in a glass vial.

26 September 2025

Tonix Pharmaceuticals announces in-licensing phase 2/3-ready monoclonal antibody designed for seasonal prevention of Lyme disease